MENU
NRC
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

NRC stock forecast, quote, news & analysis

NRC Health operates as a humanized healthcare and support organization... Show more

NRC
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
A.I.Advisor
a Summary for NRC with price predictions
Sep 11, 2026

NRC in upward trend: price may ascend as a result of having broken its lower Bollinger Band on September 01, 2026

NRC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 31 of 38 cases where NRC's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 82%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 46 of 61 cases where NRC's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 75%.

Following a +7.60% 3-day Advance, the price is estimated to grow further. Considering data from situations where NRC advanced for three days, in 213 of 296 cases, the price rose further within the following month. The odds of a continued upward trend are 72%.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on August 31, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on NRC as a result. In 73 of 100 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 73%.

The Moving Average Convergence Divergence Histogram (MACD) for NRC turned negative on August 31, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 49 similar instances when the indicator turned negative. In 36 of the 49 cases the stock turned lower in the days that followed. This puts the odds of success at 73%.

NRC moved below its 50-day moving average on September 11, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for NRC crossed bearishly below the 50-day moving average on September 09, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 11 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 73%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NRC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 78%.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 3 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 5 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: NRC's P/B Ratio (71.429) is very high in comparison to the industry average of (7.171). NRC has a moderately high P/E Ratio (88.000) as compared to the industry average of (44.460). NRC's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.499). Dividend Yield (0.028) settles around the average of (0.045) among similar stocks. P/S Ratio (3.310) is also within normal values, averaging (5.983).

The Tickeron SMR rating for this company is 26 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is 41 (best 1 - 100 worst), indicating steady price growth. NRC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NRC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 98, placing this stock worse than average.

A.I.Advisor
published Dividends

NRC paid dividends on July 10, 2026

National Research Corp NRC Stock Dividends
А dividend of $0.16 per share was paid with a record date of July 10, 2026, and an ex-dividend date of June 26, 2026. Read more...
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Teladoc Health (NYSE:TDOC).

Industry description

This industry comprises companies that provide services, such as equipment sterilization, research, physician management systems and consulting, that support the healthcare/medical industry. Examples of such companies include Laboratory Corporation of America Holdings, which operates one of the largest clinical laboratory networks in the world; Quest Diagnostics Inc., which is a clinical laboratory; and Syneos Health, which is a major clinical research organization.

Market Cap

The average market capitalization across the Services to the Health Industry Industry is 2.75B. The market cap for tickers in the group ranges from 708 to 42.48B. VEEV holds the highest valuation in this group at 42.48B. The lowest valued company is OTRKQ at 708.

High and low price notable news

The average weekly price growth across all stocks in the Services to the Health Industry Industry was -3%. For the same Industry, the average monthly price growth was 0%, and the average quarterly price growth was 19%. ACON experienced the highest price growth at 11%, while OMDA experienced the biggest fall at -14%.

Volume

The average weekly volume growth across all stocks in the Services to the Health Industry Industry was -2%. For the same stocks of the Industry, the average monthly volume growth was -32% and the average quarterly volume growth was -52%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 75
Price Growth Rating: 54
SMR Rating: 86
Profit Risk Rating: 97
Seasonality Score: -23 (-100 ... +100)
View a ticker or compare two or three
NRC
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a provider of market research services for the healthcare industry

Industry ServicestotheHealthIndustry

Profile
Details
Industry
Servicestothe Health Industry
Address
5601 South 59th Street
Phone
+1 800 388-4264
Employees
357
Web
https://www.nrchealth.com
NRC in upward trend: price may ascend as a result of having broken its lower Bollinger Band on September 01, 2026